Pharmaceutical Regulatory Affairs in the Middle East - Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Oman Palestine, Qatar, Saudi Arabia, Sudan Syria, UAE, Yemen (Seminar, London)

DUBLIN, April 10, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/fcfbhm/pharmaceutical) has announced the addition of the "Pharmaceutical Regulatory Affairs in the Middle East - Bahrain, Egypt, Iran Iraq Israel, Jordan, Kuwait, Lebanon, Libya, Oman Palestine, Qatar, Saudi Arabia, Sudan Syria, UAE, Yemen (Seminar, London)" conference to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The Pharmaceutical Regulatory Affairs in the Middle East seminar will take place on the 19th & 20th May 2014 at The Rembrandt Hotel, London

BENEFITS OF ATTENDING THIS MEETING:

- Gain an overview of the regulatory environment in the Middle East

- Understand the economic and cultural background to the markets

- Clarify procedures for company and product registration

- Discuss harmonisation and recent developments in the region:- Centralised Registration in the Gulf (GCC-DR), Middle East Regulatory Conference (MERC), MERC follow up activities, Industry regulatory activities

- Opportunities to meet, network and share experiences with other Industry colleagues

WHY SHOULD YOU ATTEND

This seminar will provide you with an essential overview of the key areas of regulatory affairs in the Middle East. This two day course will focus on practical aspects to assist with regulatory affairs in the region. The course will include interactive discussion sessions to allow you to exchange experiences with other delegates. 

WHO SHOULD ATTEND

This seminar will be of particular interest to:

- Anyone involved in pharmaceutical regulatory affairs in the Middle East

- Anyone new to the region

- Anyone interested in an update of recent developments

A Certificate of Attendance for Professional Development will be given to each participant who completes the course

DATES:

19 May 2014 Start: 09.30 - Finish: 17.00
20 May 2014 Start: 09.00 - Finish: 17.00

REGISTRATION & COFFEE

19 May 2014 09.00

VENUE & ACCOMMODATION

The Rembrandt Hotel, 11 Thurloe Place, London SW7 2RS

DIRECTIONS:

Opposite V&A Museum. Nearest underground station: South Kensington.

NOTE: Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged 

Key Topics Covered: 

The 2 Days will cover Regulatory Activities in: Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Oman, Palestine, Qatar, Saudi Arabia, Sudan, Syria, UAE, Yemen

Welcome and Introduction

The Pharmaceutical Regulatory Environment in the Middle East

- Markets and Culture
- Healthcare
- Business Culture
- Regulatory Environment and Characteristics
- General Regulatory Requirements
- Company and Product Registration
- Variations and Renewals
- Regulatory Summary 

Economic Overview of the Middle East

- Population and GDP per capita
- Unemployment rate
- GDP Real Growth Rate
- Inflation Rate
- Healthcare spend per capita

Harmonisation and Recent Developments in the Region

- Centralised Registration in the Gulf (GCC-DR)
- Middle East Regulatory Conference (MERC)
- MERC Follow Up Activities
- Industry Regulatory Groups and Activities

Discussion will take place throughout the two days 

Speakers 

Heba Hashem has been working with Regulatory Affairs in the Middle East formore than 20 years. She has a Pharmaceutical and Business background being a graduate of the Faculty of Pharmacy (Cairo University) in addition to an MBA at Maastricht School of Business. Heba is the Regulatory Affairs and Quality Assurance Manager at Gambro, Middle East & Africa. Prior to her current position, she was heading the Middle East regulatory affairs function in Bayer Health Care for 10 years, responsible for introducing Biotech, Medical Devices, Pharmaceutical and Consumer Care products to the Middle East markets. Heba also provides consulting services and regulatory training to several multinational pharmaceutical companies as well as global regulatory consulting firms.

Ilona Putz founded PULONA Emerging Markets based in the UAE. Her company is dedicated to creating and developing tailor-made business concepts for clients in the healthcare sector across the Middle East. She holds an MBA Degree from George Washington University and attended a Finance programe at Harvard, Business School. Ilona has worked in the Pharmaceutical Industry since 1988 for companies like MSD, SmithKline Beecham, Karl Engelhard and HEXAL where she has held the position of Regulatory Affairs Regional Manager, responsible for regulatory affairs and later on in commercial operations for countries in the Middle East and Africa. Between 2005 and August 2008 she was Regional Head, Middle East, for Sandoz International, Germany, responsible for all commercial and business development activities. Ilona consults for RegAff for the Middle East which is the only Global Specialist Regulatory Affairs company with a broad geographical coverage, and for Emergo Group, which is a global consultancy company for Medical Devices.

NOTE: Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged 

For more information visit http://www.researchandmarkets.com/research/fcfbhm/pharmaceutical

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets